Serum Institute of India, world’s biggest vaccine producer, asked by Delhi to keep more doses in country
An office worker in India’s Maharashtra state develops flu-like symptoms – and upsets the vaccination plans of a British fortysomething in lockdown thousands of miles away.
Such is the butterfly effect of the global scramble for Covid-19 vaccines, with a surge in Indian cases over the past week, as well as an acceleration of the country’s own vaccination rollout, resulting in a major shortage in Britain that could delay jabs for at least a month for people under the age of 50.
